Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Tables 5-8 from Pembrolizumab and Paclitaxel in Patients with HR+/HER2− Breast Cancer with HER2-Enriched or Basal-like Subtypes
  1. Home
  2. Publications
  3. Supplementary Tables 5-8 from Pembrolizumab and Paclitaxel in Patients with HR+/HER2− Breast Cancer with HER2-Enriched or Basal-like Subtypes

Supplementary Tables 5-8 from Pembrolizumab and Paclitaxel in Patients with HR+/HER2− Breast Cancer with HER2-Enriched or Basal-like Subtypes

Authors:
  • BCBenedetta Conte
    Benedetta Conte
  • FBFara Brasó-Maristany
    Fara Brasó-Maristany
  • TPTomás Pascual
    Tomás Pascual
  • CHCristina Hernando
    Cristina Hernando
  • SVSilvia Vázquez
    Silvia Vázquez
  • SBSalvador Blanch
    Salvador Blanch
  • Mafalda Oliveira
    Mafalda Oliveira
  • JVJuan Antonio Virizuela
    Juan Antonio Virizuela
  • MMMontserrat Muñoz
    Montserrat Muñoz
  • ESElia Seguí
    Elia Seguí
  • Adela Rodriguez-Hernandez
    Adela Rodriguez-Hernandez
  • MLMaria Jesus Vidal Losada
    Maria Jesus Vidal Losada

Open Access
Publisher website
Google Scholar
  • 1 April 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.31911061
Abstract
Tables S5-8 showing results from univariate analysis for ORR, CBR, PFS and OS
Keywords
  • BREAST CANCER
  • BASAL-LIKE SUBTYPES
  • SUBTYPES TABLES
  • SUPPLEMENTARY TABLES
  • SHOWING RESULTS
  • UNIVARIATE ANALYSIS
  • CBR
  • BREAST
  • ORR
  • PFS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.